Drug-Induced Lupus Following mRNA COVID-19 Vaccination and Monoclonal Antibody Infusion for Treatment of COVID-19 Infection

Authors

  • Timothy Nguyen, D.O. University of Kansas School of Medicine-Wichita
  • Stephen Wanjala, M.D. University of Kansas School of Medicine-Wichita
  • Abdul Rahman Akkawi, M.D. University of Kansas School of Medicine-Wichita
  • Kyle Rowe, M.D. Robert J. Dole VA Medical Center
  • Basit Malik, M.D. Robert J. Dole VA Medical Center

DOI:

https://doi.org/10.17161/kjm.vol17.21515

Keywords:

drug-induced lupus, COVID-19 Vaccine, papules and plaques, Monoclonal Antibody Infusion

Metrics

Metrics Loading ...

Downloads

Published

2024-04-26

Issue

Vol. 17 No. 2 (2024): Mar. - Apr.

Section

Case Reports

License

Copyright (c) 2024 Timothy Nguyen, D.O., Stephen Wanjala, M.D., Abdul Rahman Akkawi, M.D., Kyle Rowe, M.D., Basit Malik, M.D.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Nguyen, T., Wanjala, S., Akkawi, A. R., Rowe, K., & Malik, B. (2024). Drug-Induced Lupus Following mRNA COVID-19 Vaccination and Monoclonal Antibody Infusion for Treatment of COVID-19 Infection. Kansas Journal of Medicine, 17(2), 36-38. https://doi.org/10.17161/kjm.vol17.21515